@Armyne
in response, apologies for some reason reply not working.
Good question, I expect the ads will be brought back to 5 shares and all the shares will be valued in US dollars so you will have currency risk, if not dual listed. (Expect full listing on Nasdaq more expensive so dual listing even more so. However not sure so anyone please correct.)My losses have increase as pound has strengthened recently. However most of the earnings will be US dollars so that risk there anyway. If they did it all in ADS expect push back from charges. However I do not believe this will question will even arise until we start really motoring. So next month (fingers crossed)I do believe @Yankee is correct, US tend to have higher valuations. I believe experience has given them a better understanding of long term risk and reward. Always looking for next Apple or Amazon.regards Yelrom
- Forums
- ASX - By Stock
- MSB
- Cell Therapy News/Articles
Cell Therapy News/Articles, page-9334
-
- There are more pages in this discussion • 8,709 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
NEWS
Biotech innovator secures $5.5M R&D tax incentive refund – major boost for cutting-edge programs
NEWS
Exceptional lithium assays uncovered at Falcon Lake – expanding mineralisation, big potential ahead
Add MSB (ASX) to my watchlist
|
|||||
Last
96.0¢ |
Change
0.025(2.67%) |
Mkt cap ! $1.096B |
Open | High | Low | Value | Volume |
95.0¢ | 96.5¢ | 94.0¢ | $1.231M | 1.291M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 94461 | 95.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
96.0¢ | 61151 | 6 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 94461 | 0.950 |
6 | 59977 | 0.945 |
9 | 154571 | 0.940 |
4 | 44875 | 0.935 |
5 | 92633 | 0.930 |
Price($) | Vol. | No. |
---|---|---|
0.960 | 61151 | 6 |
0.965 | 46785 | 5 |
0.970 | 48228 | 6 |
0.975 | 64461 | 2 |
0.980 | 31269 | 3 |
Last trade - 16.10pm 12/09/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |